News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
CEOs de las empresas Nuage Therapeutics, Ona Therapeutics y SpliceBio
Nuage Therapeutics, Ona Therapeutics, and SpliceBio are leading the wave of biotech innovation in Barcelona
Healthcare · Rare diseases · Personalized medicine · Advanced therapies
Las biotecnológicas Nuage Therapeutics, Ona Therapeutics y SpliceBio, con sede en el Parque…
Partners - Parc Científic de Barcelona
Thumbnail
John Nicols joins ZYMVOL’s board of directors
Corporate
Partners - Zymvol Biomodeling
Científica observando a través de un microscopio
deepull secures oversubscribed €50 million Series C financing to advance UllCORE diagnostic system for direct-from-blood rapid pathogen detection
Healthcare · Access to innovation · Financing
Round co-led by Columbus Venture Partners, Panakès Partners and Mérieux Equity Partners
Partners - Asabys Partners
Estudios Gate2Brain
Validation of Gate2Brain Technology in the Transport of Antibodies to the Brain Opens the Avenue of the Next Generation of CNS Therapeutics with Improved Delivery to the Brain
Healthcare · Innovative drugs
Together, these studies reinforce the concept that advanced peptide-based brain shuttle…
Partners - Gate2Brain
La sede de Oryzon
ORYZON capta 30 millones de euros en una ampliación de capital internacional
Financing
Priced at €2.35 per share, representing a 15.44% discount on the 5-day VWAP
Partners - Oryzon Genomics
Sede de ORYZON
ORYZON continues to strengthen its patent portfolio for vafidemstat
Healthcare · Innovative drugs
Oryzon secures new patents in Europe and Japan for vafidemstat, extending protection until 2040 for…
Partners - Oryzon Genomics
Foto recurso cancer
ORYZON announces first patient dosed in NCI-sponsored Phase I/II clinical trial of iadademstat plus immune checkpoint inhibitors in 1L extensive stage Small Cell Lung Cancer
Healthcare · Innovative drugs
Oryzon Genomics has launched a clinical trial in the U.S. to evaluate for the first time the…
Partners - Oryzon Genomics
Nota Convertible
Convertible Note vs. Capital Increase
Digitalization
The convertible note is a financing instrument that initially functions as a loan and is…
Partners - GENESIS Biomed
NOTICIA BCN
BCN HEALTH publishes a study evaluating the costs due to productivity losses associated to cirrhosis in Spain
Healthcare · Access to innovation
Premature mortality from cirrhosis in Spain had an economic impact of over €2.4 billion in 2021,…
Partners - BCN Health